Clinical Trial Update: A Study of Avutometinib and Defactinib in People With Thyroid Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of Avutometinib and Defactinib for thyroid cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Avutometinib (avutometinib)
• Defactinib (defactinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thyroid Cancer | Phase 2 | Status: RECRUITING